Glaxo head blames corruption allegations in China on handful of managers

The head of drugs giant GlaxoSmithKline has sought to blame a handful of senior managers for corruption allegations it is facing in China and said the company itself had been a victim of their actions.

Sir Andrew Witty said bosses at the multinational pharmaceuticals company’s London headquarters knew nothing of the millions of pounds in bribes allegedly being paid to doctors and health officials to boost sales and raise prices.